Age-related loss of muscle mass, muscle strength and muscle function (sarcopenia) 17 lead to decline in physical performance, loss of independence and lower quality of life.
174
Secondary outcome: Sarcopenia
175
The European Working Group on Sarcopenia in Older People (EWGSOP) suggests a conceptual 176 staging of sarcopenia as "pre-sarcopenia" (low muscle mass), "sarcopenia" (low muscle mass and 177 low muscle strength OR low physical performance) and "severe sarcopenia" (low muscle mass, low 178 muscle strength and low physical performance). In this study, muscle mass will be estimated from 185 ‫ܯܯ‬ሺ݇݃ሻ = −0.543 + ሺ0.162 * ‫ݕܾ݀‬ ‫‪ሻ‬ݏݏܽ݉‬ + ሺ0.151 * ݈݂ܿܽ ‫‪݁݊ܿ݁ሻ‬ݎ݂݁݉ݑܿݎ݅ܿ‬ Grip strength will be used as a measure of muscle strength, and cut-off points are described in 186 previous section. SPPB (cut-off of 8 points) and gait speed (cut-off at 0.8m/s) will be used as a 187 measure of muscle performance. All cut-off points used are in accordance with the EWGSOP group. In addition, we assume that the standard deviation after the intervention period is 1.42 in 273 both groups. A sample size of 41 participants is required in each group to detect a statistically 274 significant mean difference of 0.9 points at significance level of 5% and with power of 80% using a 275 two-sided test. As the participants are of old age, we expect a dropout/missing frequency of 20 %,
276
thus we aim at including 50 participants in each group.
277
Statistical analyzes
278
Demographic and clinical characteristics of participants in each group will be described as 279 means and standard deviations or frequencies and percentages, as appropriate. A linear mixed 280 model will be estimated to assess the effect of MPH on primary outcome, SPPB, in the intervention 281 and placebo groups throughout the 12-months follow-up. The model will include fixed effects for 282 time component up to second-order, group allocation and the interaction between the two. Random 283 effects for participants will be included to correctly adjust estimates for possible intra-participant 284 correlations due to repeated measurements for each participant. Random slopes for time component 285 will be considered. A significant interaction between time and group allocation would imply 286 differences in SPPB score between groups throughout the follow-up. As participants will be 287 recruited from different municipalities, an intra-municipality cluster effect might be present in data.
288
To correctly adjust for such a cluster effect, also random effects on municipality-level will be 289 included into the models. Pairwise comparisons will be performed by deriving individual time point 290 contrasts within each group with corresponding 95% confidence intervals and p-values. The results
291
will further be adjusted for a number of covariates (age, sex, education, living alone, seafood intake, 292 nutritional status, vitamin D level and energy intake). The model will then be reduced by applying
293
Akaike's Information Criterion (AIC). Secondary outcomes, HQOL measured by a sum score of 294 EQ-5D-5L and health measured on VAS scale, will be assessed by similar model. Four-category 295 secondary outcome sarcopenia will be assessed by ordinal regression for longitudinal data with the 296 same fixed and random effects as in the models above. The results will be tabulated and presented 297 graphically for easier interpretation.
298
To assess whether nutrition is associated to SPPB, HQOL and sarcopenia at baseline three 299 regression models will be estimated. Linear mixed model will be estimated for outcomes SPBB and 300 HQOL, while ordinal regression model for longitudinal data will be estimated for sarcopenia, a 301 four-category ordinal outcome. Random effects for municipality will be included in the models.
302
Nutrition will be main fixed effect in all models. The models will further be adjusted for a number of 
321
The population of interest is older people either receiving municipal help, or recruited from 322 advertisements in local media, senior centers etc. People with moderate or severe cognitive 323 impairment, considered not to have the capacity to give written informed consent, are not invited to 324 join the study and this is a limitation. However, we consider the recruitment procedure to provide a 325 selection of participants who are potentially representative for the pre-frail part of the elderly 326 population, thus being the target population for the intervention. Being frail partly overlaps the 327 common idea of being "old and weak". Frailty is not synonymous with comorbidity or disability; 328 comorbidity is rather a risk factor for frailty, and disability could be an outcome of frailty [38] . Fried 329 provided a definition of frailty as a clinical syndrome in which three or more of the following criteria 330 were present: unintentional weight loss, self-reported exhaustion, weakness (grip strength), slow 331 walking speed, and low physical activity [38] . Later, these key indicators of frailty have been 332 discussed, and concerns were raised about the value of self-reported exhaustion and muscle 333 weakness. The use of slow gait speed, low physical activity, weight loss, and cognitive impairment,
334
are still regarded as strong indicators of frailty [39] . All of these factors may also reflect poor 335 nutritional status and more studies on associations between nutrition and frailty are needed to meet 336 the challenges of frailty in late life. This study will focus on the sarcopenia related indicators of 337 frailty in elderly, and the possibility of preventing sarcopenia and frailty trough nutritional 338 interventions.
339
A strength of this study is the comprehensive data collection. As to our knowledge, no previous 340 study of physical performance in elderly has a thorough assessment of the participants' nutrition 341 intake and nutritional status like this study. The documentation of malnutrition in home dwelling 342 elderly is sparse, although a prevalence study of 340 home-dwelling elderly receiving home care 343 services in Oslo, Norway reported that 46% was categorized as being, or at risk of being, 344 malnutritioned [40] . Malnutrition in elderly is a serious matter of concern, and at the University of
345
Oslo cost effectiveness of preventing compared to treating malnutrition has been estimated to a 346 saving of 800 million Norwegian kroner (ca. 86 mill €) [41] . In case of insufficient intake of calories 347 (negative energy balance), dietary proteins are used for energy utilization rather than muscle protein 348 synthesis [5, 42] . General malnutrition may therefore increase sarcopenia development despite 349 protein supplements. Thus, both general nutrition and protein nutrition status must be controlled
350
for when assessing effects of protein supplements on sarcopenia development.
351
Interventions counteracting age related sarcopenia and helping people maintain physical 352 functioning are needed to meet the challenges of increasing life span. As the average life span in
353
Norway now exceeds 80 years, we aim to delay the need for help and care, both in a socioeconomic 354 view but also to add quality to the extra years of life. We know that exercise and nutrition are 
419
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36
Strengths and limitations of this study:
37
• The study is designed as a randomized clinical trial (RCT), and the intervention is placebo 38 controlled and double blinded.
39
• A strength of this study is the comprehensive data collection, with physical and
40
anthropometric measures related to a thorough assessment of nutritional intake,
41
nutritional status and view on nutrition.
42
• The intervention period for this study is 6 to 12 months, making the study appropriate for 43 documenting potential preventive effects on age-related loss of muscle function or 44 strength.
45
• A limitation of this study may be the anthropometric method used to assess muscle mass. 
69
Proteins and amino acids are among the nutrients suggested to counteract or delay sarcopenia 70 [11, 12] , and a case-control study of sarcopenic and non-sarcopenic older people in the United 
143
Recruitment will begin in one municipality and expand from there until 100 participants are 144 included. All participants will be asked to sign a letter of consent at the first home visit. Participants
145
will be recruited and allocated from October 2017 to August 2018, and the follow-up time will be one 146 year.
147
Ethical approval
148
The study will be conducted in accordance with the Declaration of Helsinki and was approved participants, and we will ensure that our participants participate in the study voluntarily.
152
Participants will be given both oral and written information about the study twice before they
153
provide their consent to participate. First, they will receive information from either posters/flyers or 154 their home care nurse, and secondly, they will be offered the opportunity to ask the researcher 155 questions directly before signing the written consent form. Furthermore, they will be informed about 156 their right to withdraw from the study with no consequences at any time.
157
Patient and Public involvement
158
The baseline assessment was administered to elderly persons during the development of the 159 study design; however, the burden of the intervention was not assessed by elderly people. Results
160
from the study will be disseminated to study participants through newsletters and open lectures. 
179
Gait speed alone is nearly as useful as the full battery for predicting disability. However, the 180 assessment of balance and chair-rise ability are clinically important [29] .
181
Secondary outcome: Handgrip strength
182
Handgrip strength is measured to the nearest 0.1 kg using the Jamar Plus+ digital hand 183 dynamometer. We will record three trials from each hand, with participants in a sitting position
184
and the arm at a 90-degree angle, as described in Roberts et al. [30] . 
192
Health-related quality of life will be assessed by the EQ-5D-5L questionnaire [32] . The
193
EQ-5D-5L consists of the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS 
228
Nutritional intake
229
Daily energy (kcal/day) and protein intake (g/day) will be estimated using a 24-hour recall of
230
food intake, following the protocol and method described in the Newcastle 85+study (freely 
232
Norwegian participants, we use the food-portion illustrated booklet (with a corresponding list of 233 weights) from the Norwegian study "Ungkost 2000" [40] .
234
Conducted using the multiple-pass recall (MPR) method, 24-hour food recall was considered 235 the preferred method for dietary assessment among the oldest old (85+ years), based on both
236
performance and practical applicability in this age group [41] . 
244
Views on nutrition and need for nutritional support.
245
A questionnaire developed for this study, asks participants to agree or disagree with statements 246 about food and nutrition, e.g. "I prefer to eat alone" or "Food doesn't taste like it used to". Moreover,
247
we ask the participants whether they receive help preparing and eating their meals, and who they 248 prefer to consult for nutritional advice. These data will be presented descriptively in relation to 249 nutritional status and intake.
250

Intervention
251
The participants will take the supplement in tablet form and will be instructed to take five 
262
Compliance
263
Compliance will be assessed by calculating the percentage of supplement taken. The 264 participants will be asked to keep a record of their supplement intake, and questions on compliance
265
will be asked at the 6-and 12-month follow-ups. 
286
Statistical analyses
287
The demographic and clinical characteristics of the participants in each group will be described 
300
HQOL measured by the EQ-5D-5L and health as measured by the VAS scale will be assessed by 301 similar models. The results will be tabulated and presented graphically to facilitate their 302 interpretation.
303
To assess whether nutrition is associated with SPPB, HQOL and handgrip strength at baseline,
304
linear mixed models will be estimated. Nutrition will be the main fixed effect in all models. The 
377
A limitation of our study may be the anthropometric method used to assess muscle mass.
378
According 
536
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• The intervention period for this study is 6 to 12 months, making the study appropriate for 
69
121
Study design
122
The study is a randomized controlled double-blinded trial. Comprehensive data collection will 123 be used to examine the participants' nutritional status and physical function. Data will be collected 124 at baseline and 6 and 12 months after the start of the intervention. Possible effects of the 125 supplemented MPH will be assessed by examining differences between the intervention and 126 placebo groups throughout the follow-up period.
127
Recruitment
128
The participants will be men and women 65 years old and older. Exclusion criteria include 129 active cancer illness or progressive muscle illness (e.g. multiple sclerosis or Lou Gehrig's disease),
130
diabetes, kidney failure, short life expectancy (<1 year), and allergies to fish protein.
131
Participants will be recruited both through home care services and by advertising for 
142
Recruitment will begin in one municipality and expand from there until 100 participants are 143 included. All participants will be asked to sign a letter of consent at the first home visit. Participants
144
will be recruited and allocated from October 2017 to August 2018, and the follow-up time will be one 145 year.
146
147
The study will be conducted in accordance with 
227
228
Daily energy (kcal/day) and protein intake (g/day) will be estimated using a 24-hour recall of 229 food intake, following the protocol and method described in the Newcastle 85+study (freely 
231
Norwegian participants, we use the food-portion illustrated booklet (with a corresponding list of 232 weights) from the Norwegian study "Ungkost 2000" [40] .
233
The multiple-pass recall (MPR) method can accurately assess intakes regardless of the subjects'
234
body mass index [41, 42] . As this study recruits participants without an upper age limit, a dietary 
241
Both MPR and FFQ measured higher intakes than the weighed intake in the 85+ study. This 242 might be due to an overestimation of intake in the two retrospective methods, but as prospective 243 methods tend to affect food intake [44] , the retrospective methods still might be more representative 244 of true intake. Seafood intake will be assessed by a validated FFQ [45] .
245
246
A questionnaire developed for this study, asks participants to agree or disagree with statements 247 about food and nutrition, e.g. "I prefer to eat alone" or "Food doesn't taste like it used to". Moreover,
248
we ask the participants whether they receive help preparing and eating their meals, and who they 249 prefer to consult for nutritional advice. These data will be presented descriptively in relation to 250 nutritional status and intake.
251
Intervention
252
301
HQOL measured by the EQ-5D-5L and health as measured by the VAS scale will be assessed by 302 similar models. The results will be tabulated and presented graphically to facilitate their 303 interpretation.
304
305
linear mixed models will be estimated. Nutrition will be the main fixed effect in all models. The 306 models will be further adjusted for a number of other important variables including age, gender,
307
living status, seafood intake, vitamin D level, protein nutrition markers, habitual protein intake,
308
protein intake, and energy intake.
309
As participants will be recruited from different municipalities, within-municipality
310
correlations might be present in the data. To correctly adjust for such correlations, random effects for 311 municipality will be included in all models. The multiple models will be reduced by applying 
360
Interventions designed to counteract age-related sarcopenia and help older people to maintain 361 physical functioning are needed to meet the challenges of the increasing life span. As the average life 362 span in Norway now exceeds 80 years, we aim to delay the need for help and care, not only from a 363 socioeconomic perspective but also to increase the quality of the additional years of life. We know 364 that exercise and nutrition are important factors in preventing muscle loss [8] . However, when we 365 are the most vulnerable for muscle loss, e.g. during bed rest after injury or illness, both appetite and 366 the ability to exercise are reduced. Thus, the use of food supplementation to maintain muscle health 367 in these situations will highly benefit an ageing population. 
378
379
According to the European Working Group on Sarcopenia in Older People (EWGSOP) consensus on to be assessed to identify sarcopenia [2] . 
532
For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml BMJ Open   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
